Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study

Field Value
Model ID09-047-01
Model NameLosartan Intervention For Endpoint (LIFE) Risk Score - MACCE
Pubmed ID20001655
First AuthorKjeldsen
JournalBlood Pressure
Year2009
TitlePredictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study
Primary Index ConditionPopulation Sample
Secondary Index ConditionHypertension
OutcomeMACCE
Model Sample Size9193
Cohort Sample Size9193
Number of Events1096
Follow-Up DurationLong (>6 months)
AUROC0.733
Calibration Reported1
CovariatesAge (women, per 10 years); Male sex; Log urinary albumin:creatinine ratio (per 10-fold); Age (men, per 10 years); Current smoker; History of stroke or transient ischemic attack; History of diabetes; History of atrial fibrillation; History of ischemic heart disease; Total cholesterol (per mmol/l); Exercise >30 min twice/week; LVH by Sokolow-Lyon voltage (per 10 mm); LVH by Cornell product (per 1000 mm-s)
Mesh TermsTo be updated
Number of Validations0

External Validations